Shoulder Innovations (NYSE:SI) Raised to “Hold” at Wall Street Zen

Shoulder Innovations (NYSE:SI) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a research note issued on Saturday.

Shoulder Innovations Stock Up 2.4%

Shares of NYSE SI opened at $14.09 on Friday. The firm has a market capitalization of $214.59 million and a price-to-earnings ratio of -0.47. Shoulder Innovations has a fifty-two week low of $11.75 and a fifty-two week high of $17.94.

Insiders Place Their Bets

In other news, Director Geoffrey B. Pardo bought 100,000 shares of the stock in a transaction on Friday, August 1st. The stock was acquired at an average price of $15.00 per share, with a total value of $1,500,000.00. Following the acquisition, the director directly owned 2,380,482 shares in the company, valued at approximately $35,707,230. This trade represents a 4.39% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Lsv Associates Ii, Llc bought 266,666 shares of the stock in a transaction on Friday, August 1st. The stock was purchased at an average cost of $15.00 per share, with a total value of $3,999,990.00. Following the acquisition, the insider owned 1,885,136 shares in the company, valued at approximately $28,277,040. This represents a 16.48% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 778,382 shares of company stock worth $11,675,730. Company insiders own 1.71% of the company’s stock.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.